cognitive cybersecurity intelligence

News and Analysis

Search

New patent expiration for United Therap drug ORENITRAM

DrugPatentWatch reports that the drug Orenitram, marketed by United Therap and available from one supplier, is protected by fourteen patents and has two Paragraph IV challenges. The generic ingredient in Orenitram is treprostinil diolamine. This drug has 59 patent family members in eight countries.

Source: www.drugpatentwatch.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts